Fuyuan Pharmaceutical announced that its wholly-owned subsidiary Fuyuan Pharmaceutical Co., Ltd. has received the "Supplementary Application Approval Notice" issued by the National Medical Products Administration for "Gentamicin Sulfate Eye Ointment" and "Tetracycline Eye Ointment." In 2023, the sales of Gentamicin Sulfate Eye Ointment in urban physical pharmacies in China were approximately 0.184 billion yuan, and the sales of Tetracycline Eye Ointment were approximately 0.74 million yuan.
福元医药：子公司获药品补充申请批准
Fuyuan Pharmaceutical: Subsidiary approved for Pharmaceutical supplementary application.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated